Low‐dose rituximab induction therapy is effective in immunological high‐risk renal transplantation without increasing cytomegalovirus infection

Objectives To analyze the effect and impact of low‐dose rituximab induction therapy on cytomegalovirus infection in living‐donor renal transplantation. Methods A total of 92 recipients undergoing living‐donor renal transplantation at Okayama University Hospital from May 2009 to August 2018 were evaluated retrospectively. Indications for preoperative rituximab (200 mg/body) were the following: (i) ABO major mismatch; (ii) ABO minor mismatch;...